Proposition - PharmXpert Academy

322 2007 Korea Pharmaceutical Industry Directory
2. AngioLab, Inc.
1. Company Information
Company AngioLab, Inc.
Representative Min-Young Kim E-mail angiolab@angiolab.co.kr
Representative
Phone No.
82-42-520-5786
Representative
Fax No.
82-42-520-5787
Homepage www.angiolab.co.kr
Address (Zip-Code 305-811) 461-6 Jeonmin-dong Yuseong-gu Daejeon, Korea
Research
Institute Address
(Zip-Code 302-735) 439-6 Doma-2 dong Seo-gu Daejeon, Korea
Year of
Establishment
1999 Sales (‘06) 0.5 Million US$
The Number of
Total
The Number of
Total
Employees (06‘) 7 Researcher (‘06) 6
Contact Person Youngshin Lee Contact Phone 82-42-520-5786
Contact E-mail angio@angiolab.co.kr Contact Fax 82-42-520-5787
Introduction of Company
AngioLab is a biotechnology company developing angiogenesis inhibitors and stimulators.
The company focuses on the discovery of valuable lead molecules with anti-angiogenic activities
from various sources and has several candidates including natural products, organic compounds,
and recombinant proteins. AngioLab has been awarded government research grants for
angiogenesis research and development.
The company filed Korean and foreign patents that are registered or pending for the use of
those candidates as angiogenesis inhibitors.
Recently, AngioLab launched functional food, Ob-X in a way of developing anti-obesity drugs
(herbal medicine). The Ob-X shows reduction of visceral fat in human studies with negligible side
effect.
AngioLab has concentrated on developing oral dosage form of anti-angiogenic candidates with
little side effects since angiogenesis inhibitors should be administered to patients for a long time
to treat or prevent angiogenesis-dependent diseases such as cancer, obesity, ocular diseases,
arthritis and psoriasis.
AngioLab has excellent pipeline in a stage of pre-clinical to clinical phase Ⅱ and is seeking
for strategic and cooperate partner companies for further development and international
distributions of the products.
We are confident on our candidates, which hold great promise as anti-angiogenic drugs.
AngioLab produces and supplies angiogenesis-related proteins such as MMPs (Matrix
metalloproteinases) and angiogenic factors for research purpose and also provides in vitro and
in vivo assay service for angiogenesis research.